Table 1.
Herbs | Main Active Chemical Constituents | Animal Model/Tumor Cell Line | Anti-Cancer Activities/Outcome | Molecular Mechanisms/Outcome | References |
---|---|---|---|---|---|
Ginseng | Ginsenoside Rh2 | MDA-MB-231 and MCF-7 breast cancer cell lines | Anti-proliferative and apoptosis | (i) Induce changes in hypo-methylated genes (ii) Mediate G(0)/G(1) phase cell cycle arrest (iii) inhibit the production of inflammatory cytokines (iv) Obstruct nuclear factor (NF)-κB signaling and mitogen-activated protein kinase pathways |
[30,32,34,35] |
Ginseng | Ginsenoside Rg3 | MDA-MB-231 and MCF-7 breast cancer cell lines | Anti-proliferative | (i) Decrease expression of cyclin D1 and cyclin A (ii) Arrest cells in the G-1 phase |
[36] |
Garlic | Diallyl disulfide | MDA-MB-468 cancer cell line and female Swiss albino mice with EAC tumor | Decrease tumor growth and apoptosis | (i) Induce apoptosis by promoting caspase-3 expression (ii) Prevent oxidative degradation of anti-tumor protein, p53 |
[37] |
Curcuma longa | Curcumin | MDA-MB-231 and BT-483 breast cancer cells | Anti-proliferative effect in a dose-dependent manner | (i) Downregulation of NFkappaB inducing genes (ii) Decrease transcription of matrix metalloproteinases (MMPs)-1 and cyclin D |
[38] |
Curcuma longa | Curcumin | MCF-7 and MDA-MB-231 breast cancer cells | Inhibition of cell proliferation and induction of apoptosis | Down-regulation of the beta-catenin pathway | [39] |
Echinacea | Extracts of Echinacea purpurea | BT-549 mammalian breast cancer cell | Inhibition of cell proliferation | Mechanism not given | [40] |
Arctium lappa (greater burdock) | Arctigenin | MDA-MB-231 breast cancer cells | Induce apoptosis | (i) Activation of the ROS/p38 MAPK pathway (ii) Induction of mitochondrial caspase-independent pathways with increased Bax/Bcl-2 ratio | [41] |
Arctium lappa (greater burdock) | Arctigenin | MCF-7 and MDA-MB-231 human breast cancer cell lines | Anti-metastatic effect | Inhibiting the NF-κB, Akt/MAPK signaling pathways, and MMP-9 | [42] |
Flaxseed (dietary) | Lignans | Athymic mice inoculated with human MCF-7 cancer cells | Inhibition of cell proliferation and induced apoptosis | Reduced mRNA expressions of cyclin D1, epidermal growth factor receptor and Bcl2 | [43] |
Nigella sativa | Thymoquinone | T-47D and MDA-MB-468 breast cancer cells | Induced apoptosis | (i) Promote G (1) phase arrest via translation upregulation of procaspase-3 and Bax (ii) Inhibition of cyclin D1 and cyclin E, and PARP cleavage alongside downregulation of the gene expression of survivin, Bcl-2 and Bcl-xL |
[44] |
Nigella sativa | Thymoquinone | MCF-7 breast cancer cell line | Induced apoptosis | Upregulation of the expression of tumor suppressor gene p53 in a time-dependent manner | [45] |
Nigella sativa | Thymoquinone | MDA-MB-231 triple-negative breast cancer cells | Anti-metastatic effect | Downregulate the expressions of CXCR4 in breast cancer cells in a time- and dose-dependent manner | [46] |